Description
Accession
P35916
Source
DNA sequence encoding Human VEGF R3/FLT4 including a C-hFc tag was expressed in HEK293 Cells.
Molecular weight
Recombinant Human VEGF R3/FLT4 is a protein consisting of amino acid residues [Tyr25-Ile776] ,The protein has a predicted MW of 111.3 kDa. Due to glycosylation, the protein migrates to 135-155 kDa based on Tris-Bis PAGE result..
Purity
>95%, as determined by SDS-PAGE and HPLC
Biological Activity
see methods section
Endotoxin
Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg(1EU/µg).
Presentation
Recombinant Human VEGF R3/FLT4 was lyophilized from 0.2 µm filtered PBS solution pH7.4
Reconstitution
Centrifuge vial to ensure maximal product extraction, recommended:20sec, 5K RPM
Storage
The lyophilized protein is stable for at least 2 years from date of receipt at -20° C.
Usage
This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes.
Interactor
Interactor
Interactor
Biological Process
Molecular function
Molecular function
Methods
Human VEGF R3/FLT4 Protein Tris-Bis PAGE
- Human VEGF R3 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Human VEGF R3/FLT4 Protein SEC-HPLC
- The purity of Human VEGF R3 is greater than 95% as determined by SEC-HPLC.
Human VEGF R3/FLT4 Protein ELISA Data
- Immobilized Human VEGF-C, His Tag at 1μg/ml (100μl/well) on the plate. Dose response curve for Human VEGF R3, hFc Tag with the EC50 of 19.8ng/ml determined by ELISA.
